Valuation In Life Sciences..-

Código: 264114 Marca: Springer Publishing

R$ 829,92

até 4x de R$ 207,48 sem juros

ou R$ 788,42 via Pix

Qtde: Adicionar ao carrinho Disponibilidade: 10 dias úteis Estoque: 209 unidades

Parcelas
- 1x de R$ 829,92 sem juros
- 2x de R$ 414,96 sem juros
- 3x de R$ 276,64 sem juros
- 4x de R$ 207,48 sem juros
R$ 788,42
R$ 829,92

First Complete Guide To Valuation In Life Sciences (Pharma, Biotech, Medtech)

Step-By-step Explanation Of How To Practice Valuation Of Projects And Contracts

With Relevant Data And Many Real-Life Examples And Exercises

This Book Is The First Complete Guide To Valuation In Life Sciences For Industry Professionals, Investors, And Academics. Boris Bogdan And Ralph Villiger Introduce The Characteristics Of Drug And Medical Device Development, Explain How To Translate These Into The Valuation, And Provide Valuable Industry Data. After Guiding The Reader Through The Theory Of Valuation, Including Dcf, Decision Trees, And Real Options, The Authors Demonstrate How To Value Projects, Patents, Licences, Firms, And Stocks On Real-Life Examples, Even Treating Complex Licence And Company Structures. Special Emphasis Is Put On The Practicability Of The Proposed Methods By Including Many Hands-On Examples, Without Compromising On Realistic Results.

the 3Rd Edition Of The Successful Work Includes New Studies About Success Rates And About Drug Development In The Biotech Industry And Their Influence On Valuation.

Content Level » Professional/Practitioner

Keywords » Biotech - Biotechnology - Medtech - Pharma - Real Options - Valuation - Venture Capital

Related Subjects » Health Informatics

ISBN	9783642108198
Autor(a)	Villiger, Ralph
Editora	Springer Publishing
Idioma	Inglês Americano
Edição	3
Ano de edição	2010
Páginas	158
Acabamento	Brochura
Dimensões	16,51 X 24,76